Used as an intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective kinase inhibitors. Its structure supports the construction of bioactive molecules with enhanced metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting inflammatory and oncological diseases. The presence of amine and ester functionalities allows for further derivatization, enabling the creation of diverse compound libraries for biological screening.